Selasa 22 Dec 2015 16:17 WIB

Japan and the US use immunotherapy for cancer treatment

Rep: Fira Nursya'bani/ Red: Julkifli Marbun
illustration
Foto: ist
illustration

REPUBLIKA.CO.ID, SINGAPORE -- In Japan and the United States (US), the use of immunotherapy is approved to treat patients with melanoma (skin cancer). The researchers found that after one year, overall survival rate in patients who received immunotherapy for advanced stage of melanoma is 94 percent.

Meanwhile, the survival rate for two years reached 88 percent. The US Agency for Food and Drug Administration (FDA) approved the certification of immunotherapy to treat people which is affected by lung cancer advanced stage. Clinical trials that were conducted on lung cancer showed promising results, which could improve patient survival from 8.2 months to 9.2 months.

Immunotherapy is a relatively new form of anti-cancer treatment that has given promising results in the past years. Although promising, the new treatment methods do not stop human struggle against cancer.

"It is important that the patient knows, like all medical treatments, there are certain limitations that can be achieved by immunotherapy," said Medical Director and Senior Consultant of Medical Oncology at Parkway Cancer Center, Dr Ang Peng Tiam, in a press release received by Republika.co.id.

To that end, people have duty and responsibility to share and remove misunderstandings about the immunotherapy.

Yuk koleksi buku bacaan berkualitas dari buku Republika ...
Advertisement
Yuk Ngaji Hari Ini
يَسْتَفْتُوْنَكَۗ قُلِ اللّٰهُ يُفْتِيْكُمْ فِى الْكَلٰلَةِ ۗاِنِ امْرُؤٌا هَلَكَ لَيْسَ لَهٗ وَلَدٌ وَّلَهٗٓ اُخْتٌ فَلَهَا نِصْفُ مَا تَرَكَۚ وَهُوَ يَرِثُهَآ اِنْ لَّمْ يَكُنْ لَّهَا وَلَدٌ ۚ فَاِنْ كَانَتَا اثْنَتَيْنِ فَلَهُمَا الثُّلُثٰنِ مِمَّا تَرَكَ ۗوَاِنْ كَانُوْٓا اِخْوَةً رِّجَالًا وَّنِسَاۤءً فَلِلذَّكَرِ مِثْلُ حَظِّ الْاُنْثَيَيْنِۗ يُبَيِّنُ اللّٰهُ لَكُمْ اَنْ تَضِلُّوْا ۗ وَاللّٰهُ بِكُلِّ شَيْءٍ عَلِيْمٌ ࣖ
Mereka meminta fatwa kepadamu (tentang kalalah). Katakanlah, “Allah memberi fatwa kepadamu tentang kalalah (yaitu), jika seseorang mati dan dia tidak mempunyai anak tetapi mempunyai saudara perempuan, maka bagiannya (saudara perempuannya itu) seperdua dari harta yang ditinggalkannya, dan saudaranya yang laki-laki mewarisi (seluruh harta saudara perempuan), jika dia tidak mempunyai anak. Tetapi jika saudara perempuan itu dua orang, maka bagi keduanya dua pertiga dari harta yang ditinggalkan. Dan jika mereka (ahli waris itu terdiri dari) saudara-saudara laki-laki dan perempuan, maka bagian seorang saudara laki-laki sama dengan bagian dua saudara perempuan. Allah menerangkan (hukum ini) kepadamu, agar kamu tidak sesat. Allah Maha Mengetahui segala sesuatu.”

(QS. An-Nisa' ayat 176)

Berita Lainnya
Advertisement
Advertisement
Advertisement